Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 51 of 95, showing 5 Applications out of 471 total, starting on record 251, ending on 255

# Protocol No Study Title Investigator(s) & Site(s)

251.

ECCT/19/11/04   Second line switch to Dolutegravir (2SD) study
    Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial               
Principal Investigator(s)
1. Loice Achieng
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Thika Level 5 Hospital (Kiambu county)
4. Kiambu Level 5 Hospital (Kiambu county)
 
View

252.

ECCT/19/11/03   A Pilot BE study for Enalpril 5mg
    A bioequivalent pilot study of a locally-produced brand of enalapril tablets:  a key step towards implementation of bioequivalent study regulatory requirements in East Africa   
Principal Investigator(s)
1. Simon Njoroge Njenga
Site(s) in Kenya
Kenya Medical Research Institute
 
View

253.

ECCT/19/11/02   PrEP and dPEP
    PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis   
Principal Investigator(s)
1. Dr.Elizabeth Bukusi Ann Bukusi
Site(s) in Kenya
KEMRI/CMR/RCTP Kisumu-Lumumba Sub-County Hospital
 
View

254.

ECCT/19/11/01   A study to determine if candidate malaria vaccines are safe, effective, and induce immunity among Kenyan adults.
    Safety, immunogenicity, and efficacy of R21/Matrix M (R21/MM) and ChAd63/MVA-ME-TRAP in the context of controlled human malaria infection: A Phase IIb Trial in Kenyan Adults.   
Principal Investigator(s)
1. Melissa Kapulu
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
View

255.

ECCT/19/10/03   Smoking Cessation Study for PLHIV
    Optimizing Smoking Cessation Interventions For People Living With Human Immunodeficiency Virus in Nairobi, Kenya   
Principal Investigator(s)
1. Dr. Seth Scott Himelhoch Seth Scott Himelhoch
Site(s) in Kenya
Mathari National Teaching and Referral Hospital
 
View